Erika Ross is the director of Applied Research at Abbott Neuromodulation, leading applied research strategy, external partnerships, portfolio, and execution. Applied research includes computational modeling, pre-clinical, feasibility, and clinical safety trials that feed new products and indications within Abbott Neuromodulation. Prior to her role at Abbott, Erika was the neuroscience director at Cala Health, a Stanford Biodesign-incubated start-up that has been developing a noninvasive, digitally enabled neuromodulation solution for treating essential tremor. She has held roles of increasing leadership at Cala Health as the company completed development and prepared for commercialization. Prior to Cala Health, Erika held the roles of assistant professor of Neurologic Surgery and deputy director of the Surgical Device Innovation Accelerator at the Mayo Clinic.